title: A novel mouse model of nonalcoholic steatohepatitis with significant insulin resistance.
abstract: Currently available models insufficiently reflect the pathogenic alternation of nonalcoholic steatohepatitis\NASH), such as insulin resistance. The present study aimed to characterize a novel NASH model caused by feeding the diet containing conjugated linoleic acid (CLA). In this study, mice were fed a control diet or the diet containing 0.5% CLA for 8 weeks. The insulin tolerance test (ITT) and homeostasis model assessment of insulin resistance (HOMA-IR) were used to determine the extent of insulin resistance. Liver lipotoxicity and inflammation were assessed by endoplasmic reticulum (ER) stress, autolipophagy, recruitment of Kupffer cells and hepatic stellate cell (HSC) activation. We found that liver weight was markedly increased, and histopathological examination showed marked macrosteatosis with focal hepatocellular death through apoptosis, and mild pericellular fibrosis with Kupffer cell recruitment and HSC activation, as well as light chain IIIβ-positive cells and enhanced ER stress in mice fed the CLA-containing diet. Enhanced synthesis and reduced β-oxidation of fatty acids resulted in their accumulation and lipotoxicity in hepatocytes. A biophotonic technology revealed lipid droplet accumulation in the liver from mice fed the CLA-containing diet, and Raman spectroscopic analysis indicated that these lipid droplets predominantly contained saturated fatty acids. Elevated fasting insulin levels, abnormal ITT and HOMA-IR confirmed the marked insulin resistance in these mice. Decreased phosphorylation of the insulin-signaling molecule Akt was partially responsible for the significant insulin resistance. In conclusion, Mice fed the diet containing CLA-developed steatohepatitis with marked insulin resistance, which is similar to the characteristics observed in NASH patients. The further characterization of this model would be particularly useful for revealing the critical role of insulin resistance in NASH development in conditions such as metabolic syndrome, diabetes and obesity.
authors.affiliation: 1] Western Human Nutrition Research Center, Agricultural Research Service, USDA, Davis, CA, USA [2] Department of Nutrition, University of California, Davis, Davis, CA, USA.
authors.forename: Yuriko
authors.initials: Y
authors.lastname: Adkins
authors.forename: Iwan W
authors.initials: IW
authors.lastname: Schie
authors.forename: Dawn
authors.initials: D
authors.lastname: Fedor
authors.forename: Aurosis
authors.initials: A
authors.lastname: Reddy
authors.forename: Samantha
authors.initials: S
authors.lastname: Nguyen
authors.forename: Ping
authors.initials: P
authors.lastname: Zhou
authors.forename: Darshan S
authors.initials: DS
authors.lastname: Kelley
authors.forename: Jian
authors.initials: J
authors.lastname: Wu
mesh_terms: D000818:Animals; D001343:Autophagy; D004195:Disease Models, Animal; D059865:Endoplasmic Reticulum Stress; D005227:Fatty Acids / Q000096:biosynthesis; D005234:Fatty Liver / Q000209:etiology* / Q000473:pathology; D005260:Female; D005355:Fibrosis; D007333:Insulin Resistance; D007728:Kupffer Cells / Q000502:physiology; D044243:Linoleic Acids, Conjugated / Q000009:adverse effects*; D050356:Lipid Metabolism; D008099:Liver / Q000378:metabolism / Q000473:pathology*; D051379:Mice; D008810:Mice, Inbred C57BL; D009929:Organ Size; D013059:Spectrum Analysis, Raman
chemical_list: D005227:Fatty Acids; D044243:Linoleic Acids, Conjugated